Avricore Health Inc.
AVCR.V
TSX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 15.86% | 14.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.86% | 14.72% | |||
| Cost of Revenue | 6.49% | 13.11% | |||
| Gross Profit | 32.18% | 17.64% | |||
| SG&A Expenses | -16.72% | 97.85% | |||
| Depreciation & Amortization | 40.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.63% | 39.11% | |||
| Operating Income | 153.29% | -319.85% | |||
| Income Before Tax | -287.66% | -432.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -287.66% | -432.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -287.66% | -432.41% | |||
| EBIT | 153.29% | -319.85% | |||
| EBITDA | 544.73% | -123.82% | |||
| EPS Basic | -284.62% | -425.00% | |||
| Normalized Basic EPS | 150.00% | -500.00% | |||
| EPS Diluted | -469.23% | -425.00% | |||
| Normalized Diluted EPS | 150.00% | -500.00% | |||
| Average Basic Shares Outstanding | 0.84% | 0.53% | |||
| Average Diluted Shares Outstanding | 0.84% | -4.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||